"use strict";(globalThis.webpackChunkwebsite=globalThis.webpackChunkwebsite||[]).push([[80057],{4124:(e,n,i)=>{i.r(n),i.d(n,{assets:()=>a,contentTitle:()=>l,default:()=>h,frontMatter:()=>o,metadata:()=>t,toc:()=>d});const t=JSON.parse('{"id":"skills/modern_drug_rehab_computer/references/mat-medications","title":"Medication-Assisted Treatment (MAT) Deep Dive","description":"Overview","source":"@site/docs/skills/modern_drug_rehab_computer/references/mat-medications.md","sourceDirName":"skills/modern_drug_rehab_computer/references","slug":"/skills/modern_drug_rehab_computer/references/mat-medications","permalink":"/docs/skills/modern_drug_rehab_computer/references/mat-medications","draft":false,"unlisted":false,"tags":[],"version":"current","sidebarPosition":2,"frontMatter":{"title":"Medication-Assisted Treatment (MAT) Deep Dive","sidebar_label":"Medication-Assisted Treatme...","sidebar_position":2}}');var r=i(74848),s=i(28453);const o={title:"Medication-Assisted Treatment (MAT) Deep Dive",sidebar_label:"Medication-Assisted Treatme...",sidebar_position:2},l="Medication-Assisted Treatment (MAT) Deep Dive",a={},d=[{value:"Overview",id:"overview",level:2},{value:"Medications for Opioid Use Disorder",id:"medications-for-opioid-use-disorder",level:2},{value:"Buprenorphine (Suboxone, Subutex, Sublocade)",id:"buprenorphine-suboxone-subutex-sublocade",level:3},{value:"How It Works",id:"how-it-works",level:4},{value:"Formulations",id:"formulations",level:4},{value:"Induction Protocol",id:"induction-protocol",level:4},{value:"Precipitated Withdrawal Warning",id:"precipitated-withdrawal-warning",level:4},{value:"Micro-Dosing Protocols (Bernese Method)",id:"micro-dosing-protocols-bernese-method",level:4},{value:"Methadone",id:"methadone",level:3},{value:"How It Works",id:"how-it-works-1",level:4},{value:"Dosing",id:"dosing",level:4},{value:"Clinic Structure",id:"clinic-structure",level:4},{value:"Naltrexone (Vivitrol)",id:"naltrexone-vivitrol",level:3},{value:"How It Works",id:"how-it-works-2",level:4},{value:"Formulations",id:"formulations-1",level:4},{value:"Important Considerations",id:"important-considerations",level:4},{value:"Medications for Alcohol Use Disorder",id:"medications-for-alcohol-use-disorder",level:2},{value:"Naltrexone (for Alcohol)",id:"naltrexone-for-alcohol",level:3},{value:"Acamprosate (Campral)",id:"acamprosate-campral",level:3},{value:"Disulfiram (Antabuse)",id:"disulfiram-antabuse",level:3},{value:"Medication Comparison Table",id:"medication-comparison-table",level:2},{value:"Common Myths vs. Facts",id:"common-myths-vs-facts",level:2},{value:"Questions to Ask Your Provider",id:"questions-to-ask-your-provider",level:2}];function c(e){const n={code:"code",h1:"h1",h2:"h2",h3:"h3",h4:"h4",header:"header",hr:"hr",li:"li",ol:"ol",p:"p",pre:"pre",strong:"strong",table:"table",tbody:"tbody",td:"td",th:"th",thead:"thead",tr:"tr",ul:"ul",...(0,s.R)(),...e.components};return(0,r.jsxs)(r.Fragment,{children:[(0,r.jsx)(n.header,{children:(0,r.jsx)(n.h1,{id:"medication-assisted-treatment-mat-deep-dive",children:"Medication-Assisted Treatment (MAT) Deep Dive"})}),"\n",(0,r.jsx)(n.h2,{id:"overview",children:"Overview"}),"\n",(0,r.jsx)(n.p,{children:"MAT combines FDA-approved medications with counseling and behavioral therapies. It's evidence-based, reduces mortality by up to 50%, and is considered the gold standard for opioid use disorder treatment."}),"\n",(0,r.jsx)(n.h2,{id:"medications-for-opioid-use-disorder",children:"Medications for Opioid Use Disorder"}),"\n",(0,r.jsx)(n.h3,{id:"buprenorphine-suboxone-subutex-sublocade",children:"Buprenorphine (Suboxone, Subutex, Sublocade)"}),"\n",(0,r.jsx)(n.h4,{id:"how-it-works",children:"How It Works"}),"\n",(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Partial opioid agonist"}),": Activates opioid receptors partially"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Ceiling effect"}),": After a certain dose, effects plateau (overdose protection)"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"High receptor affinity"}),": Blocks other opioids from binding"]}),"\n"]}),"\n",(0,r.jsx)(n.h4,{id:"formulations",children:"Formulations"}),"\n",(0,r.jsxs)(n.table,{children:[(0,r.jsx)(n.thead,{children:(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.th,{children:"Brand"}),(0,r.jsx)(n.th,{children:"Form"}),(0,r.jsx)(n.th,{children:"Frequency"}),(0,r.jsx)(n.th,{children:"Notes"})]})}),(0,r.jsxs)(n.tbody,{children:[(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:(0,r.jsx)(n.strong,{children:"Suboxone"})}),(0,r.jsx)(n.td,{children:"Sublingual film/tablet"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"Contains naloxone (deters injection)"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:(0,r.jsx)(n.strong,{children:"Subutex"})}),(0,r.jsx)(n.td,{children:"Sublingual tablet"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"Buprenorphine only (pregnancy)"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:(0,r.jsx)(n.strong,{children:"Sublocade"})}),(0,r.jsx)(n.td,{children:"Monthly injection"}),(0,r.jsx)(n.td,{children:"Monthly"}),(0,r.jsx)(n.td,{children:"Extended-release, steady levels"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:(0,r.jsx)(n.strong,{children:"Brixadi"})}),(0,r.jsx)(n.td,{children:"Weekly/monthly injection"}),(0,r.jsx)(n.td,{children:"Weekly or monthly"}),(0,r.jsx)(n.td,{children:"Newer option"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:(0,r.jsx)(n.strong,{children:"Zubsolv"})}),(0,r.jsx)(n.td,{children:"Sublingual tablet"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"Higher bioavailability"})]})]})]}),"\n",(0,r.jsx)(n.h4,{id:"induction-protocol",children:"Induction Protocol"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"BUPRENORPHINE INDUCTION (Traditional)\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nPREREQUISITE: Must be in withdrawal\n- COWS score \u2265 12 (moderate withdrawal)\n- Last short-acting opioid use: 12-24 hours\n- Last methadone use: 24-72 hours\n- Last fentanyl use: 72+ hours (longer half-life)\n\nDAY 1:\n\u251c\u2500\u2500 Start with 2-4mg sublingual\n\u251c\u2500\u2500 Wait 1-2 hours, assess response\n\u251c\u2500\u2500 If still withdrawing: add 2-4mg\n\u251c\u2500\u2500 Max Day 1: 8mg typically\n\u2514\u2500\u2500 Goal: Comfort, not sedation\n\nDAY 2:\n\u251c\u2500\u2500 Give Day 1 total dose at once\n\u251c\u2500\u2500 May increase by 4mg if needed\n\u2514\u2500\u2500 Target: 12-16mg total\n\nDAY 3-7:\n\u251c\u2500\u2500 Titrate to comfort\n\u251c\u2500\u2500 Most stable at 16-24mg\n\u2514\u2500\u2500 Max approved dose: 24mg/day\n\nCOMMON MISTAKE:\nStarting too early \u2192 precipitated withdrawal\nWait for REAL withdrawal, not just anxiety about withdrawal\n"})}),"\n",(0,r.jsx)(n.h4,{id:"precipitated-withdrawal-warning",children:"Precipitated Withdrawal Warning"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"PRECIPITATED WITHDRAWAL\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nWhat happens: Buprenorphine has HIGHER affinity than full agonists.\nIt kicks fentanyl/heroin OFF receptors \u2192 sudden withdrawal.\n\nSymptoms (within 1-4 hours of first dose):\n\u251c\u2500\u2500 Severe anxiety, agitation\n\u251c\u2500\u2500 Vomiting, diarrhea\n\u251c\u2500\u2500 Muscle cramps, bone pain\n\u251c\u2500\u2500 Sweating, goosebumps\n\u251c\u2500\u2500 Elevated heart rate\n\u2514\u2500\u2500 Often WORSE than natural withdrawal\n\nTreatment:\n\u251c\u2500\u2500 Supportive care (fluids, comfort meds)\n\u251c\u2500\u2500 May need to add more buprenorphine\n\u251c\u2500\u2500 Very rarely: full agonist (controversial)\n\u2514\u2500\u2500 Prevention: WAIT for true withdrawal\n\nWith fentanyl (the new challenge):\n\u251c\u2500\u2500 Fentanyl stores in fat \u2192 slow release\n\u251c\u2500\u2500 Traditional 24-hour wait often insufficient\n\u251c\u2500\u2500 Some providers use micro-dosing protocols\n\u2514\u2500\u2500 Discuss with your medical team\n"})}),"\n",(0,r.jsx)(n.h4,{id:"micro-dosing-protocols-bernese-method",children:"Micro-Dosing Protocols (Bernese Method)"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"MICRO-INDUCTION (for fentanyl users)\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nAllows starting buprenorphine WITHOUT full withdrawal.\nPatient continues using while slowly adding buprenorphine.\n\nDay 1: 0.5mg buprenorphine\nDay 2: 1mg\nDay 3: 2mg\nDay 4: 4mg\nDay 5: 8mg\nDay 6: 12mg\nDay 7: 16mg (stop other opioid use)\n\nWHY IT WORKS:\nLow doses gradually occupy receptors without\ndisplacing all the fentanyl at once.\n\nCAUTION:\n\u251c\u2500\u2500 Should be done under medical supervision\n\u251c\u2500\u2500 Not appropriate for everyone\n\u251c\u2500\u2500 Requires patient to follow complex schedule\n\u2514\u2500\u2500 Discuss with your provider\n"})}),"\n",(0,r.jsx)(n.h3,{id:"methadone",children:"Methadone"}),"\n",(0,r.jsx)(n.h4,{id:"how-it-works-1",children:"How It Works"}),"\n",(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Full opioid agonist"}),": Fully activates receptors"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Long half-life"}),": 24-36 hours (once daily dosing)"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"No ceiling effect"}),": CAN cause overdose if misused"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Heavily regulated"}),": Dispensed at specialized clinics"]}),"\n"]}),"\n",(0,r.jsx)(n.h4,{id:"dosing",children:"Dosing"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"METHADONE DOSING\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nINDUCTION:\n\u251c\u2500\u2500 Start: 20-30mg on Day 1\n\u251c\u2500\u2500 Observe for 2-4 hours\n\u251c\u2500\u2500 Max Day 1: 30-40mg usually\n\u2514\u2500\u2500 Low and slow (peak effects at 3-4 hours)\n\nTITRATION:\n\u251c\u2500\u2500 Increase 5-10mg every 3-5 days\n\u251c\u2500\u2500 Wait for steady state (3-5 half-lives)\n\u251c\u2500\u2500 Typical range: 60-120mg\n\u251c\u2500\u2500 Some need higher (fast metabolizers)\n\u2514\u2500\u2500 Goal: No cravings, no withdrawal, no sedation\n\nSPLIT DOSING:\nSome patients metabolize fast and need twice-daily dosing.\nSigns: withdrawal symptoms in evening, not lasting 24 hours.\n"})}),"\n",(0,r.jsx)(n.h4,{id:"clinic-structure",children:"Clinic Structure"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"METHADONE CLINIC PHASES\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nPhase 1 (New patient):\n\u251c\u2500\u2500 Daily clinic visits\n\u251c\u2500\u2500 Observed dosing\n\u251c\u2500\u2500 Building trust and stability\n\u2514\u2500\u2500 Duration: 90 days typically\n\nPhase 2:\n\u251c\u2500\u2500 2-3 take-homes per week\n\u251c\u2500\u2500 Regular counseling\n\u251c\u2500\u2500 Clean UDS required\n\u2514\u2500\u2500 Duration: 6+ months\n\nPhase 3:\n\u251c\u2500\u2500 6 take-homes per week\n\u251c\u2500\u2500 Monthly counseling minimum\n\u251c\u2500\u2500 Long-term stability\n\u2514\u2500\u2500 Years of compliance\n\nTAKE-HOME CRITERIA:\n\u251c\u2500\u2500 Clean urine drug screens\n\u251c\u2500\u2500 Counseling attendance\n\u251c\u2500\u2500 No behavioral issues\n\u251c\u2500\u2500 Time in treatment\n\u2514\u2500\u2500 Varies by state/clinic\n"})}),"\n",(0,r.jsx)(n.h3,{id:"naltrexone-vivitrol",children:"Naltrexone (Vivitrol)"}),"\n",(0,r.jsx)(n.h4,{id:"how-it-works-2",children:"How It Works"}),"\n",(0,r.jsxs)(n.ul,{children:["\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Opioid antagonist"}),": BLOCKS receptors completely"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"No agonist activity"}),": Cannot get high on opioids while taking"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Not addictive"}),": No withdrawal from naltrexone itself"]}),"\n",(0,r.jsxs)(n.li,{children:[(0,r.jsx)(n.strong,{children:"Also used for alcohol"}),': Reduces cravings, blocks "high"']}),"\n"]}),"\n",(0,r.jsx)(n.h4,{id:"formulations-1",children:"Formulations"}),"\n",(0,r.jsxs)(n.table,{children:[(0,r.jsx)(n.thead,{children:(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.th,{children:"Form"}),(0,r.jsx)(n.th,{children:"Brand"}),(0,r.jsx)(n.th,{children:"Frequency"}),(0,r.jsx)(n.th,{children:"Notes"})]})}),(0,r.jsxs)(n.tbody,{children:[(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Monthly injection"}),(0,r.jsx)(n.td,{children:"Vivitrol"}),(0,r.jsx)(n.td,{children:"Every 28 days"}),(0,r.jsx)(n.td,{children:"380mg IM in gluteal"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Daily pill"}),(0,r.jsx)(n.td,{children:"ReVia/generic"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"50mg oral"})]})]})]}),"\n",(0,r.jsx)(n.h4,{id:"important-considerations",children:"Important Considerations"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"NALTREXONE REQUIREMENTS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nMUST be opioid-free before starting:\n\u251c\u2500\u2500 7-14 days from short-acting opioids\n\u251c\u2500\u2500 10-14 days from methadone/buprenorphine\n\u2514\u2500\u2500 Naloxone challenge test can verify\n\nWHY THE WAIT:\nNaltrexone will precipitate withdrawal if ANY opioids\nare still on receptors. Unlike buprenorphine,\nnaltrexone has ZERO agonist activity to provide comfort.\n\nNOT APPROPRIATE FOR:\n\u251c\u2500\u2500 Active opioid use (can't get opioid-free)\n\u251c\u2500\u2500 Chronic pain requiring opioids\n\u251c\u2500\u2500 Those not ready for abstinence-based approach\n\u251c\u2500\u2500 Unreliable for daily oral (injection preferred)\n\u2514\u2500\u2500 Liver disease (check LFTs)\n\nOVERDOSE RISK AFTER STOPPING:\nWhen naltrexone wears off, tolerance is GONE.\nUsing previous dose after stopping \u2192 overdose risk.\nCritical education point.\n"})}),"\n",(0,r.jsx)(n.h2,{id:"medications-for-alcohol-use-disorder",children:"Medications for Alcohol Use Disorder"}),"\n",(0,r.jsx)(n.h3,{id:"naltrexone-for-alcohol",children:"Naltrexone (for Alcohol)"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"NALTREXONE FOR ALCOHOL\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nSame medication, different mechanism for alcohol:\n\u251c\u2500\u2500 Blocks endorphin release from drinking\n\u251c\u2500\u2500 Drinking becomes less pleasurable\n\u251c\u2500\u2500 Can continue drinking (Sinclair Method)\n\u251c\u2500\u2500 Or use for abstinence support\n\u2514\u2500\u2500 50mg oral daily OR monthly Vivitrol\n\nSINCLAIR METHOD:\n\u251c\u2500\u2500 Take naltrexone 1 hour before drinking\n\u251c\u2500\u2500 Continue drinking as usual\n\u251c\u2500\u2500 Brain learns drinking \u2260 reward\n\u251c\u2500\u2500 Gradual reduction over 6-12 months\n\u251c\u2500\u2500 78% success rate in Finnish studies\n\u2514\u2500\u2500 NOT abstinence-based (controversial)\n"})}),"\n",(0,r.jsx)(n.h3,{id:"acamprosate-campral",children:"Acamprosate (Campral)"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"ACAMPROSATE\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nHOW IT WORKS:\n\u251c\u2500\u2500 Restores glutamate/GABA balance\n\u251c\u2500\u2500 Brain chemistry disrupted by chronic alcohol\n\u251c\u2500\u2500 Reduces post-acute withdrawal symptoms\n\u2514\u2500\u2500 Supports abstinence maintenance\n\nDOSING:\n\u251c\u2500\u2500 666mg three times daily (1998mg total)\n\u251c\u2500\u2500 Start after alcohol withdrawal complete\n\u251c\u2500\u2500 Takes 5-7 days to reach effectiveness\n\u2514\u2500\u2500 Continue for 12 months typically\n\nBEST FOR:\n\u251c\u2500\u2500 Maintaining abstinence (not reducing)\n\u251c\u2500\u2500 Those who have detoxed\n\u251c\u2500\u2500 Post-acute withdrawal symptoms\n\u251c\u2500\u2500 Can combine with naltrexone\n\u2514\u2500\u2500 Safe with liver disease\n"})}),"\n",(0,r.jsx)(n.h3,{id:"disulfiram-antabuse",children:"Disulfiram (Antabuse)"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:"DISULFIRAM\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nHOW IT WORKS:\n\u251c\u2500\u2500 Blocks alcohol metabolism\n\u251c\u2500\u2500 Acetaldehyde builds up \u2192 very sick\n\u251c\u2500\u2500 Creates aversion to drinking\n\u2514\u2500\u2500 Deterrent effect (fear of reaction)\n\nTHE REACTION (if you drink):\n\u251c\u2500\u2500 Flushing, headache\n\u251c\u2500\u2500 Nausea, vomiting\n\u251c\u2500\u2500 Rapid heartbeat, low BP\n\u251c\u2500\u2500 Difficulty breathing\n\u251c\u2500\u2500 Can be severe/dangerous\n\u2514\u2500\u2500 Starts within 10 min, lasts hours\n\nDOSING:\n\u251c\u2500\u2500 250-500mg daily\n\u251c\u2500\u2500 Must wait 12 hours after last drink\n\u251c\u2500\u2500 Effects last 1-2 weeks after stopping\n\u2514\u2500\u2500 Cannot have ANY alcohol (cooking, mouthwash)\n\nBEST FOR:\n\u251c\u2500\u2500 Highly motivated patients\n\u251c\u2500\u2500 Those with external accountability\n\u251c\u2500\u2500 Supervised administration works best\n\u251c\u2500\u2500 NOT for impulsive drinkers\n\u2514\u2500\u2500 Medical monitoring recommended\n"})}),"\n",(0,r.jsx)(n.h2,{id:"medication-comparison-table",children:"Medication Comparison Table"}),"\n",(0,r.jsxs)(n.table,{children:[(0,r.jsx)(n.thead,{children:(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.th,{children:"Medication"}),(0,r.jsx)(n.th,{children:"Type"}),(0,r.jsx)(n.th,{children:"Frequency"}),(0,r.jsx)(n.th,{children:"Can Use While On It?"}),(0,r.jsx)(n.th,{children:"Overdose Risk"}),(0,r.jsx)(n.th,{children:"Best For"})]})}),(0,r.jsxs)(n.tbody,{children:[(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Buprenorphine"}),(0,r.jsx)(n.td,{children:"Partial agonist"}),(0,r.jsx)(n.td,{children:"Daily/monthly"}),(0,r.jsx)(n.td,{children:"No (blocked)"}),(0,r.jsx)(n.td,{children:"Low"}),(0,r.jsx)(n.td,{children:"Opioid maintenance"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Methadone"}),(0,r.jsx)(n.td,{children:"Full agonist"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"No (tolerance)"}),(0,r.jsx)(n.td,{children:"Medium"}),(0,r.jsx)(n.td,{children:"High-tolerance opioid users"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Naltrexone"}),(0,r.jsx)(n.td,{children:"Antagonist"}),(0,r.jsx)(n.td,{children:"Daily/monthly"}),(0,r.jsx)(n.td,{children:"No (blocked)"}),(0,r.jsx)(n.td,{children:"None from med"}),(0,r.jsx)(n.td,{children:"Abstinence-motivated"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Acamprosate"}),(0,r.jsx)(n.td,{children:"Modulator"}),(0,r.jsx)(n.td,{children:"3x daily"}),(0,r.jsx)(n.td,{children:"N/A (for alcohol)"}),(0,r.jsx)(n.td,{children:"None"}),(0,r.jsx)(n.td,{children:"Alcohol abstinence"})]}),(0,r.jsxs)(n.tr,{children:[(0,r.jsx)(n.td,{children:"Disulfiram"}),(0,r.jsx)(n.td,{children:"Aversive"}),(0,r.jsx)(n.td,{children:"Daily"}),(0,r.jsx)(n.td,{children:"DANGEROUS"}),(0,r.jsx)(n.td,{children:"None from med"}),(0,r.jsx)(n.td,{children:"Alcohol deterrence"})]})]})]}),"\n",(0,r.jsx)(n.h2,{id:"common-myths-vs-facts",children:"Common Myths vs. Facts"}),"\n",(0,r.jsx)(n.pre,{children:(0,r.jsx)(n.code,{children:'MYTH: "MAT is just substituting one drug for another"\nFACT: MAT medications are evidence-based treatments that:\n      - Normalize brain function\n      - Don\'t produce euphoria at therapeutic doses\n      - Allow people to work, parent, live fully\n      - Reduce mortality by 50%+\n\nMYTH: "You\'re not really sober on MAT"\nFACT: Recovery is not defined by medication status.\n      Stability, quality of life, and function matter.\n      Would you say a diabetic isn\'t "healthy" on insulin?\n\nMYTH: "You should get off MAT as quickly as possible"\nFACT: Research shows longer MAT duration = better outcomes.\n      Tapering is a personal decision made with your doctor.\n      There\'s no rush. Stability first.\n\nMYTH: "MAT is only for severe addiction"\nFACT: MAT is appropriate across the severity spectrum.\n      Earlier intervention often means better outcomes.\n      Don\'t need to hit "rock bottom."\n\nMYTH: "I\'ll be on MAT forever"\nFACT: Duration is individual. Some stay on long-term (fine!).\n      Others taper successfully after years of stability.\n      This is between you and your treatment team.\n'})}),"\n",(0,r.jsx)(n.h2,{id:"questions-to-ask-your-provider",children:"Questions to Ask Your Provider"}),"\n",(0,r.jsxs)(n.ol,{children:["\n",(0,r.jsx)(n.li,{children:"Which MAT option is best for my situation?"}),"\n",(0,r.jsx)(n.li,{children:"What are the side effects I should watch for?"}),"\n",(0,r.jsx)(n.li,{children:"How long should I expect to be on this medication?"}),"\n",(0,r.jsx)(n.li,{children:"What happens if I relapse while on MAT?"}),"\n",(0,r.jsx)(n.li,{children:"Can I take this medication if I'm pregnant/planning pregnancy?"}),"\n",(0,r.jsx)(n.li,{children:"Will this interfere with my other medications?"}),"\n",(0,r.jsx)(n.li,{children:"What's the plan if the first medication doesn't work?"}),"\n",(0,r.jsx)(n.li,{children:"How will we measure if this is working?"}),"\n"]}),"\n",(0,r.jsx)(n.hr,{}),"\n",(0,r.jsxs)(n.p,{children:[(0,r.jsx)(n.strong,{children:"Remember"}),": MAT is a tool, not a crutch. Combined with counseling and support, it saves lives. Talk to your medical team about what's right for you."]})]})}function h(e={}){const{wrapper:n}={...(0,s.R)(),...e.components};return n?(0,r.jsx)(n,{...e,children:(0,r.jsx)(c,{...e})}):c(e)}},28453:(e,n,i)=>{i.d(n,{R:()=>o,x:()=>l});var t=i(96540);const r={},s=t.createContext(r);function o(e){const n=t.useContext(s);return t.useMemo(function(){return"function"==typeof e?e(n):{...n,...e}},[n,e])}function l(e){let n;return n=e.disableParentContext?"function"==typeof e.components?e.components(r):e.components||r:o(e.components),t.createElement(s.Provider,{value:n},e.children)}}}]);